PTGER1 and ischemia: To determine whether EP1 receptor inhibition with a selective antagonist of EP1 receptor SC-51089 or its genetic deletion could provide neuroprotection following acute experimental TBI similarly as it was demonstrated in different models of ischemia and excitotoxicity, the anatomical and neurobehavioral outcomes were compared in WT and EP1−/− mice in separate cohorts.